検索条件

閉じる

検索結果 14070 件

フルテキストURL fulltext20230112-1.pdf
著者 Yoshitoshi, Munehisa| Horiguchi, Goro| Takahashi, Kiriko|
キーワード Human rights inclusive education court litigation reasonable accommodation symbiotic society
備考 This is an Accepted Manuscript of an article published by Taylor & Francis in [Disability & Society] on [2022-12-16], available online: http://www.tandfonline.com/10.1080/09687599.2022.2157705| This full-text file will be available in June 2024.|
発行日 2022-12-16
出版物タイトル Disability & Society
巻 39巻
号 6号
出版者 Informa UK Limited
開始ページ 1423
終了ページ 1442
ISSN 0968-7599
NCID AA10993999
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
DOI 10.1080/09687599.2022.2157705
Web of Science KeyUT 000898598900001
関連URL isVersionOf https://doi.org/10.1080/09687599.2022.2157705
フルテキストURL fulltext20230110-1.pdf Table1_20230110-1.pdf Table2_20230110-1.pdf Table3_20230110-1.pdf Table4_20230110-1.pdf Figure 1A.jpg Figure 1B.jpg Figure 1C.jpg Figure 1D.jpg Figure 1E.jpg Figure 1F.jpg
著者 Matsumoto, Kazuyuki| Kato, Hironari|
キーワード ablation techniques endoscopic ultrasonography ethanol pancreatic neoplasms radiofrequency ablation
備考 This is the peer reviewed version of the following article: [Matsumoto, K. and Kato, H. (2023), Endoscopic ablation therapy for the pancreatic neoplasms. Digestive Endoscopy. https://doi.org/10.1111/den.14468], which has been published in final form at [https://doi.org/10.1111/den.14468]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages there of by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.| This full-text file will be available in Dec. 2023.|
発行日 2022-12-13
出版物タイトル Digestive Endoscopy
巻 35巻
号 4号
出版者 Wiley
開始ページ 430
終了ページ 442
ISSN 0915-5635
NCID AA10907137
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 Japan Gastroenterological Endoscopy Society.
論文のバージョン author
PubMed ID 36366955
DOI 10.1111/den.14468
Web of Science KeyUT 000897965200001
関連URL isVersionOf https://doi.org/10.1111/den.14468
フルテキストURL fulltext20221227-2.pdf
著者 Takata, Jun| Miyake, Naoko| Saiki, Yusuke| Tada, Misako| Sasaki, Kensuke| Kubo, Toshio| Kiura, Katsuyuki| Arimoto-Kobayashi, Sakae|
キーワード Akt signal transduction Lung tumorigenesis Anti-mutagenesis DNA methylation Tobacco-specific nitrosamine Isoquercetin
発行日 2022-12-09
出版物タイトル Genes and Environment
巻 44巻
号 1号
出版者 Springer Science and Business Media LLC
開始ページ 26
ISSN 1880-7062
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s) 2022.
論文のバージョン publisher
PubMed ID 36494703
DOI 10.1186/s41021-022-00255-0
Web of Science KeyUT 000896571200001
関連URL isVersionOf https://doi.org/10.1186/s41021-022-00255-0
フルテキストURL fulltext20221223-1.pdf
著者 Kawashima, Shusuke| Togashi, Yosuke|
キーワード immune checkpoint inhibitors tumor microenvironment antitumor immunity primary resistance acquired resistance
備考 This is the peer reviewed version of the following article: [Kawashima, S, Togashi, Y. Resistance to immune checkpoint inhibitors and the tumor microenvironment. Exp Dermatol. 2022; 00: 1- 10. doi:10.1111/exd.14716], which has been published in final form at [https://doi.org/10.1111/exd.14716]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages there of by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.| This full-text will be available in Nov. 2023.|
発行日 2022-12-08
出版物タイトル Experimental Dermatology
巻 32巻
号 3号
出版者 Wiley
開始ページ 240
終了ページ 249
ISSN 0906-6705
NCID AA10958794
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
論文のバージョン author
PubMed ID 36437644
DOI 10.1111/exd.14716
Web of Science KeyUT 000894179800001
関連URL isVersionOf https://doi.org/10.1111/exd.14716
タイトル(別表記) Cases of patient discharge from the Kyushu Leprosarium in the Early Showa period
JaLCDOI 10.18926/64200
フルテキストURL jdc_002_032.pdf
著者 松岡 弘之|
抄録 Although it has been said that modern Japanese santoria for Hansen's disease quarantined patients for their entire lives, there were a small number of cases of "arrested discharges" (a "provisional discharge" when progress of the disease was halted) in the 1920s. To examine the reasons why this practice did not spread in Japan, this paper considers the background that led to the admission of patients who were later discharged from the Kyushu Sanatorium (九州療養所) to analyze two types of discharges: "Arrested discharges" and "discharge by relatives." To do so, this paper draws on the "Patient Identification Records"(身分帳) created by the Fifth Ward United Kyushu Sanatorium (now National Sanatorium Kikuchi Keifuen) to manage patients' admission and discharge from the sanatorium. This analysis clarified specific procedures of "arrested discharges" from the facility, which had previously been completely unknown, and it further revealed that regardless if the patients were discharged as an arrested case or by relatives, emphasis was placed upon their prospects for life after discharge, such as the availability of people to support their care and a minimum standard of living
キーワード Hansen's disease sanatoria quarantine modern Japan
Amo Type 研究ノート (Research note)
出版物タイトル 文明動態学
発行日 2023-03-25
巻 2巻
出版者 岡山大学文明動態学研究所
開始ページ 32
終了ページ 43
ISSN 2436-8326
資料タイプ 学術雑誌論文
言語 日本語
著作権者 ©2023 by RIDC
論文のバージョン publisher
フルテキストURL fulltext20221215-1.pdf figures20221215-1.pdf Supple_Figures20221215-1.pdf Supple_Table20221215-1.pdf
著者 Kajiwara, Yoshinori| Tazawa, Hiroshi| Yamada, Motohiko| Kanaya, Nobuhiko| Fushimi, Takuro| Kikuchi, Satoru| Kuroda, Shinji| Ohara, Toshiaki| Noma, Kazuhiro| Yoshida, Ryuichi| Umeda, Yuzo| Urata, Yasuo| Kagawa, Shunsuke| Fujiwara, Toshiyoshi|
キーワード Pancreatic cancer Chemoresistance MDSC GM-CSF Oncolytic virus
備考 This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s00262-022-03334-x| This full-text of the article will be available in Nov. 2023.|
発行日 2022-11-27
出版物タイトル Cancer Immunology, Immunotherapy
巻 72巻
号 5号
出版者 Springer Science and Business Media LLC
開始ページ 1285
終了ページ 1300
ISSN 0340-7004
NCID AA00598499
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022
論文のバージョン author
PubMed ID 36436021
DOI 10.1007/s00262-022-03334-x
Web of Science KeyUT 000889040300003
関連URL isVersionOf https://doi.org/10.1007/s00262-022-03334-x
フルテキストURL fulltext20221130-2.pdf
著者 Matsuo, Toshihiko| Noda, Hiroshi|
発行日 2022-11-27
出版物タイトル Clinical Case Reports
巻 10巻
号 11号
出版者 Wiley
開始ページ e06657
ISSN 2050-0904
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 The Authors.
論文のバージョン publisher
DOI 10.1002/ccr3.6657
フルテキストURL fulltext20221124-1.pdf DBA_Figure1_20220614_400.jpg
著者 Tamefusa, Kosuke| Muraoka, Michiko| Washio, Kana| Wakamatsu, Manabu| Shimada, Akira|
キーワード Diamond-Blackfan anemia neutropenia next-generation sequencing RPL35A variant
備考 This is the peer reviewed version of the following article: [Tamefusa, K., Muraoka, M., Washio, K., Wakamatsu, M. and Shimada, A. (2022), Late-onset familial Diamond–Blackfan anemia with neutropenia caused by RPL35A variant. Pediatrics International, 64: e15275.], which has been published in final form at [https://doi.org/10.1111/ped.15275]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages there of by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.| This is the Accepted Manuscript. This full-text does not reflect post-acceptance improvements, or any corrections.
この論文は著者最終稿版です。受理後の校正・修正を反映していないため、表現が最終版と異なる箇所があります。|
This full-text will be available in Oct. 2023.|
発行日 2022-10-18
出版物タイトル Pediatrics International
巻 64巻
号 1号
出版者 Wiley
開始ページ e15275
ISSN 1328-8067
NCID AA11320483
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 Japan Pediatric Society.
論文のバージョン author
PubMed ID 36257617
DOI 10.1111/ped.15275
Web of Science KeyUT 000869400500001
関連URL isVersionOf https://doi.org/10.1111/ped.15275
フルテキストURL fulltext20221122-2.pdf
著者 Tani, Yumeki| Ochiai, Kenta| Kaneta, Takashi|
キーワード Optical force Extracellular vesicle exosome Gold nanoparticle Optical trapping
備考 This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s44211-022-00207-2| This full-text will be available in November 2023.|
発行日 2022-11-05
出版物タイトル Analytical Sciences
巻 39巻
号 5号
出版者 Springer Science and Business Media LLC
開始ページ 643
終了ページ 651
ISSN 0910-6340
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022, The Author(s), under exclusive licence to The Japan Society for Analytical Chemistry
論文のバージョン author
PubMed ID 36334243
DOI 10.1007/s44211-022-00207-2
Web of Science KeyUT 000879131000001
関連URL isVersionOf https://doi.org/10.1007/s44211-022-00207-2
フルテキストURL fulltext20221122-1.pdf
著者 Nojima, Tsuyoshi| Obara, Takafumi| Yamamoto, Hirotsugu| Yumoto, Tetsuya| Igawa, Takuro| Aokage, Toshiyuki| Seya, Mizuki| Nakao, Atsunori| Naito, Hiromichi|
発行日 2022-11
出版物タイトル Surgery
巻 172巻
号 5号
出版者 Elsevier BV
開始ページ 1522
終了ページ 1528
ISSN 0039-6060
NCID AA00853880
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 The Author(s)
論文のバージョン publisher
PubMed ID 36088170
DOI 10.1016/j.surg.2022.07.021
Web of Science KeyUT 000875983900035
関連URL isVersionOf https://doi.org/10.1016/j.surg.2022.07.021
フルテキストURL fulltext20221116-1.pdf
著者 Takahashi, Misa| Hagiya, Hideharu| Koyama, Toshihiro| Otsuka, Fumio|
キーワード aging sexual health sexually transmitted infection spirochete syphilis
備考 This is the peer reviewed version of the following article: [Takahashi, M, Hagiya, H, Koyama, T, Otsuka, F. Trends in the incidence of syphilis in the middle-aged and older adults in Japan: A nationwide observational study, 2009–2019. Geriatr. Gerontol. Int. 2022; 22: 1019–1024. https://doi.org/10.1111/ggi.14500], which has been published in final form at [https://doi.org/10.1111/ggi.14500]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages there of by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.| This full-text will be available in Nov. 2023.|
発行日 2022-11-01
出版物タイトル Geriatrics and Gerontology International
巻 22巻
号 12号
出版者 Wiley
開始ページ 1019
終了ページ 1024
ISSN 1444-1586
NCID AA1155729X
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 Japan Geriatrics Society.
論文のバージョン author
PubMed ID 36320169
DOI 10.1111/ggi.14500
Web of Science KeyUT 000877369900001
関連URL isVersionOf https://doi.org/10.1111/ggi.14500
フルテキストURL fulltext20221110-3.pdf
著者 Nakano, Yumiko| Taira, Yuki| Sasaki, Ryo| Tadokoro, Koh| Yunoki, Taijun| Nomura, Emi| Fukui, Yusuke| Takemoto, Mami| Morihara, Ryuta| Shimozawa, Nobuyuki| Yamashita, Toru|
キーワード adrenoleukodystrophy symptomatic female carriers spastic paraplegia ABCD1
備考 This is the peer reviewed version of the following article: [Nakano, Y, Taira, Y, Sasaki, R, et al. Novel ABCD1 mutation detected in a symptomatic female carrier of adrenoleukodystrophy. Neurol Clin Neurosci. 2023; 11: 58-60. doi: 10.1111/ncn3.12667], which has been published in final form at [https://doi.org/10.1111/ncn3.12667]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages there of by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.|
発行日 2022-10-17
出版物タイトル Neurology and Clinical Neuroscience
巻 11巻
号 1号
出版者 Wiley
開始ページ 58
終了ページ 60
ISSN 2049-4173
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 Japanese Society of Neurology and John Wiley & Sons Australia, Ltd.
論文のバージョン author
DOI 10.1111/ncn3.12667
Web of Science KeyUT 000868833900001
関連URL isVersionOf https://doi.org/10.1111/ncn3.12667
フルテキストURL fulltext20221110-3.pdf
著者 Shimomae, Koichi| Sato, Takuya| Yoshida, Yuichi| Naing, Shine Shane| Miyatake, Takahisa|
キーワード Diptera Lifespan Pollination Quality control
備考 © 2022 Korean Society of Applied Entomology. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.aspen.2022.101999] .| This full-text file will be available in Oct. 2023.|
発行日 2022-12
出版物タイトル Journal of Asia-Pacific Entomology
巻 25巻
号 4号
出版者 Elsevier BV
開始ページ 101999
ISSN 1226-8615
NCID AA11262547
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 Korean Society of Applied Entomology.
論文のバージョン author
DOI 10.1016/j.aspen.2022.101999
Web of Science KeyUT 000868905600009
関連URL isVersionOf https://doi.org/10.1016/j.aspen.2022.101999
JaLCDOI 10.18926/AMO/64127
フルテキストURL 76_6_749.pdf
著者 Takami, Masanari| Yukawa, Yasutsugu| Noda, Yusuke| Yoshida, Munehito| Yamada, Hiroshi|
抄録 We provide the first report of successful salvage surgery for a post-C1 laminectomy symptomatic recurrence of a retro-odontoid pseudotumor (ROP) that caused myelopathy. The 72-year-old Japanese woman presented with an ROP causing symptomatic cervical myelopathy. With ultrasonography support, we performed the enucleation of the ROP via a transdural approach and fusion surgery for the recurrence of the mass. At the final observation 2-year post-surgery, MRI demonstrated the mass’s regression and spinal cord decompression, and the patient’s symptoms had improved. Our strategy is an effective option for a symptomatic recurrence of ROP.
キーワード recurrent retro-odontoid pseudotumor salvage surgery transdural resection C1 laminectomy ultra-sonography
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 749
終了ページ 754
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549779
Web of Science KeyUT 000905195100017
JaLCDOI 10.18926/AMO/64122
フルテキストURL 76_6_715.pdf
著者 Mohammed Zahedul Islam Nizami| Gorduysus, Melahat| Shinoda-Ito, Yuki| Yamamoto, Tadashi| Nishina, Yuta| Takashiba, Shogo| Arias, Zulema|
抄録 The failure of endodontic treatment is directly associated with microbial infection in the root canal or periapical areas. An endodontic sealer that is both bactericidal and biocompatible is essential for the success of root canal treatments. This is one of the vital issues yet to be solved in clinical dental practice. This in vitro study assessed the effectiveness of graphene oxide (GO) composites GO-CaF2 and GO-Ag-CaF2 as endodontic sealer materials. Dentin slices were coated with either the GO-based composites or commonly used root canal sealers (non-eugenol zinc oxide sealer). The coated slices were treated in 0.9% NaCl, phosphate-buffered saline (PBS), and simulated body fluid (SBF) at 37˚C for 24 hours to compare their sealing effect on the dentin surface. In addition, the radiopacity of these composites was examined to assess whether they complied with the requirements of a sealer for good radiographic visualization. Scanning electron microscopy showed the significant sealing capability of the composites as coating materials. Radiographic images confirmed their radiopacity. Mineral deposition indicated their bioactivity, especially of GO-Ag-CaF2, and thus it is potential for regenerative application. They were both previously shown to be bactericidal to oral microbes and cytocompatible with host cells. With such a unique assemblage of critical properties, these GO-based composites show promise as endodontic sealers for protection against reinfection in root canal treatment and enhanced success in endodontic treatment overall.
キーワード bioactive sealer graphene oxide mineral deposition antimicrobial activity radiopacity
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 715
終了ページ 721
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549774
Web of Science KeyUT 000905195100012
JaLCDOI 10.18926/AMO/64121
フルテキストURL 76_6_705.pdf
著者 Higashikawa, Toshihiro| Ito, Tomohiko| Mizuno, Takurou| Ishigami, Keiichiro| Kuroki, Kengo| Maekawa, Naoto| Usuda, Daisuke| Izumida, Toshihide| Yamada, Shinya| Sangen, Ryusho| Hamada, Kazu| Kiyosawa, Jun| Saito, Atsushi| Iguchi, Masaharu| Kasamaki, Yuji| Nakahashi, Takeshi| Fukuda, Akihiro| Saito, Hitoshi| Kanda, Tsugiyasu| Okuro, Masashi|
抄録 The sodium glucose transporter 2 (SGLT2) inhibitor tofogliflozin is a glucose-lowering drug that causes the excretion of surplus glucose by inhibiting SGLT2. Because of tofogliflozin’s osmotic diuresis mechanism, patients’ serum electrolytes, body fluid levels, and cardiac function must be monitored. We retrospectively analyzed the cases of 64 elderly Japanese patients with type 2 diabetes mellitus (T2DM) who received tofogliflozin for 3 months. Their HbA1c, serum electrolytes (sodium, potassium, chloride), hematocrit, brain natriuretic peptide (cardiac volume load marker) and renin and aldosterone (RAA; an index of regulatory hormones involved in body fluid retention) were continuously monitored during the investigation period. Renal function and cardiac function (by echocardiography) were assessed throughout the period. HbA1c significantly decreased (β1=−0.341, p<0.0001, linear regression analysis [LRA]). Most of the hormonal, electrolyte, and physiological parameters were maintained throughout the study period. In these circumstances, E/e’ tended to decrease (β1=−0.382, p=0.13, LRA). Compared to the baseline, E/e’ was significantly decreased at 1 and 3 months (p<0.01, p<0.05). In the higher E/e’ group (E/e’≥10, n=34), E/e’ decreased significantly (β1=−0.63, p<0.05, LRA). ΔE/e’ was correlated with body-weight change during treatment (r=0.64, p<0.01). The 3-month tofogliflozin treatment improved glycemic control and diastolic function represented by E/e’ in T2DM patients, without affecting serum electrolytes, renal function, or RAA. No negative impacts on the patients were observed. Three-month tofogliflozin treatment lowered glucose and improved cardiac diastolic function.
キーワード tofogliflozin SGLT2 inhibitor elderly patient HbA1c cardiac diastolic function
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 705
終了ページ 713
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549773
Web of Science KeyUT 000905195100011
JaLCDOI 10.18926/AMO/64120
フルテキストURL 76_6_695.pdf
著者 Onishi, Hideki| Nouso, Kazuhiro| Takaki, Akinobu| Oyama, Atsushi| Adachi, Takuya| Wada, Nozomu| Takeuchi, Yasuto| Shiraha, Hidenori| Okada, Hiroyuki|
抄録 This study sought to identify factors that are predictive of a therapeutic response to hepatic arterial infusion chemotherapy (HAIC) by focusing on the number of prior transcatheter arterial chemoembolization (TACE) sessions. To determine the parameters predicting a good response to HAIC, we retrospectively analyzed 170 patients with hepatocellular carcinoma (HCC) who received HAIC regimens comprising low-dose cisplatin combined with 5-fluorouracil (LFP) or cisplatin (CDDP) for the first time. In both the LFP and CDDP regimens, the response rates were significantly lower in patients with three or more prior TACE sessions than in those with two or fewer prior TACE sessions (LFP 57% versus 28%; p=0.01, CDDP 27% versus 6%; p=0.01). Multivariable logistic regression analysis revealed that the number of prior TACE sessions (≥ 3) was significantly associated with non-responder status (odds ratio 4.17, 95% Confidence Interval (CI) 1.76-9.86) in addition to the HAIC regimen. Multivariable analysis using the Cox proportional hazards model revealed that a larger number of prior TACE sessions (≥ 3) was a significant risk factor for survival (hazard ratio 1.60, 95% CI 1.12-2.29) in addition to Child-Pugh class, serum alpha-fetoprotein concentration, and maximum diameter of HCC. HCC patients who receive fewer prior TACE sessions (≤ 2) were found to be better responders to HAIC.
キーワード hepatic arterial infusion chemotherapy hepatocellular carcinoma refractory transcatheter arterial chemoembolization
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 695
終了ページ 703
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549772
Web of Science KeyUT 000905195100010
JaLCDOI 10.18926/AMO/64119
フルテキストURL 76_6_689.pdf
著者 Yamanouchi, Kosho| Kuba, Sayaka| Matsumoto, Megumi| Yano, Hiroshi| Morita, Michi| Sakimura, Chika| Otsubo, Ryota| Hidaka, Masaaki| Nagayasu, Takeshi| Eguchi, Susumu|
抄録 Taxanes are key drugs for patients with breast cancer. A major adverse effect of taxanes is peripheral neuropathy (PN). To investigate the ability of compression therapy using sleeves and stockings to prevent PN due to the taxane docetaxel, we conducted a single-center historical control trial. Patients receiving docetaxel at 75 mg/m2 every 3 weeks for 4 cycles as first-line chemotherapy for breast cancer were eligible. PN was evaluated using the common terminology criteria for adverse events version 4.0. The primary endpoint was the incidence of allgrade PN until 3 weeks after the fourth docetaxel administration. We evaluated 26 patients in the intervention group and compared their data to those collected retrospectively from 52 patients treated with docetaxel without compression. Neither the incidence of all-grade PN until 3 weeks after the fourth docetaxel administration (63.5% in the control group vs. 76.9% in the intervention group, p=0.31) nor that of PN grade ≥ 2 (13.5% vs. 15.4%, p=0.99) differed between the groups. In this study, the efficacy of compression therapy using sleeves and stockings to prevent PN induced by docetaxel was not demonstrated. Further clinical studies including medications or intervention are needed to reduce the incidence and severity of PN induced by chemotherapy.
キーワード breast cancer docetaxel neuropathy compression
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 689
終了ページ 694
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549771
Web of Science KeyUT 000905195100009
JaLCDOI 10.18926/AMO/64118
フルテキストURL 76_6_679.pdf
著者 Asagi, Akinori| Sakaguchi, Chihiro| Nadano, Seijin| Nishina, Tomohiro| Hamamoto, Yasushi| Kataoka, Masaaki| Yamashita, Natsumi| Tanimizu, Masahito| Hyodo, Ichinosuke|
抄録 Chemotherapy is insufficient to treat macroscopic vascular invasion (MVI) of hepatocellular carcinoma (HCC). We retrospectively investigated the treatment outcomes of patients who underwent three-dimensional conformal radiotherapy (3D-CRT) for HCC MVI and analyzed prognostic factors by multivariate analysis using a Cox proportional hazard model. Sixty-five patients were studied. MVI sites were the portal vein (n=48 patients), portal and hepatic veins (n=8), and hepatic vein (n=9). The median irradiation dose was 50 Gy. The median survival time (MST) was 7.5 months. Performance status 2 or 3, modified albumin-bilirubin grade 2b or 3, and massive/diffuse type were poor prognostic factors. Nineteen patients (29%) with a treatment effect of 3 or 4 (≥ 50% of tumor necrosis or regression) at the irradiation sites according to the Response Evaluation Criteria in Cancer of the Liver showed longer survival than those with an effect of 1 or 2 (MST 18.7 vs. 5.9 months, p<0.001). No treatment-related death occurred. The hepatic function reserve was preserved in more than 70% of patients. 3D-CRT controlled HCC MVI safely and was suggested to be a good treatment option.
キーワード hepatocellular carcinoma macroscopic vascular invasion portal vein tumor thrombosis hepatic vein tumor thrombosis three-dimensional conformal radiotherapy
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 679
終了ページ 688
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549770
Web of Science KeyUT 000905195100008
JaLCDOI 10.18926/AMO/64117
フルテキストURL 76_6_673.pdf
著者 Okazawa-Sakai, Mika| Yamamoto, Yasuko| Futagawa, Mashu| Okamura, Miki| Miyawaki, Satoko| Nishina, Tomohiro| Takehara, Kazuhiro| Kozuki, Toshiyuki| Tomida, Shuta| Hyodo, Ichinosuke| Ohsumi, Shozo| Hirasawa, Akira|
抄録 Patients found to have presumed germline pathogenic variants (PGPVs) during comprehensive genomic profiling (CGP) require genetic counseling (GC) referrals. We retrospectively investigated the outcomes of patients with PGPVs. Among 159 patients who underwent CGP, we recommended GC for the 16 patients with PGPVs (3 with [FG group] and 13 without [G Group] a family/personal history of hereditary cancer) as well as for the 8 patients with no PGPVs, but a history (F group); 2 (67%), 5 (38%), and 3 (38%) patients received GC in the FG, G, and F groups, respectively. Germline testing results were positive in 1 and 2 patients of the FG and G groups, respectively. Among the patients recommended for GC, 58% did not receive GC due to lack of interest, poor performance status, or death. CGP contributes to the identification of germline variants in patients without a history of hereditary cancer. However, the proportion of patients who undergo GC should be improved.
キーワード comprehensive genomic profiling hereditary cancer germline findings presumed germline pathogenic variant(s) genetic counseling
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 673
終了ページ 678
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549769
Web of Science KeyUT 000905195100007